Perrigo Company plc PRGO
16.83 USD -0.12 (-0.71%)
At closeNov 11, 2026, 4:00 AM EST
16.81 -0.02 -0.12%
Pre-market · Nov 11, 4:00 AM ET
16.21 Day range 16.92
9.23 52-week range 17.02
- YTD
- +20.91%
- 1 year
- +18.11%
News
benzinga.com Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields Healthcare dividend stocks PRGO (7.32%), BMY (4.06%) and GSK (3.65%) feature analyst ratings and recent company news.
marketbeat.com Perrigo Q3 Earnings Call Highlights Perrigo NYSE: PRGO reported lower third-quarter sales and earnings as cautious retailer inventory decisions and weakness in Europe weighed on results, even as the self-care company gained market…
fool.com Perrigo: 3 Key Takeaways for Long-Term Investors Perrigo agreed to divest its infant formula business. U.S. e-commerce reached 22% of Perrigo's U.S. volume.
seekingalpha.com Perrigo Company plc (PRGO) Q3 2026 Earnings Call Transcript Perrigo Company plc ( PRGO ) Q3 2026 Earnings Call November 4, 2026 8:30 AM EST Company Participants Eric Jacobson - Vice President of Global Investor Relations Albert Manzone - Interim President,…
zacks.com Perrigo (PRGO) Reports Q3 Earnings: What Key Metrics Have to Say The headline numbers for Perrigo (PRGO) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street…
benzinga.com Perrigo Q3 2026 Earnings Call Transcript Perrigo (NYSE:PRGO) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
zacks.com Perrigo (PRGO) Surpasses Q3 Earnings Estimates Perrigo (PRGO) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.8 per share a year ago.
benzinga.com Perrigo Narrows FY2026 Adj EPS Guidance from $2.25-$2.55 to $2.25-$2.45 vs $2.18 Est; Lowers FY2026 Sales Guidance from $4.019B-$4.189B to $4.011B-$4.057B vs $4.054B Est Perrigo (NYSE:PRGO) narrows FY2026 Adj EPS guidance from $2.25-$2.55 to $2.25-$2.45 vs $2.18 analyst estimate. Lowers FY2026 sales outlook from $4.019 billion-$4.189 billion to $4.011 billion-$4.057…
benzinga.com Perrigo Q3 Adj. EPS $0.60 Beats $0.50 Estimate, Sales $989.000M Beat $987.200M Estimate Perrigo (NYSE:PRGO) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.50 by 20 percent. This is a 25 percent decrease over earnings of $0.80 per share…
prnewswire.com Perrigo Reports Third Quarter 2026 Financial Results From Continuing Operations Execution of Three-S plan driving sequential improvement in operating results and market share gains across U.S. Store Brand OTC and key European brands Infant Formula divestiture expected to…
benzinga.com Canaccord Genuity Maintains Buy on Perrigo, Raises Price Target to $19 Canaccord Genuity analyst Susan Anderson maintains Perrigo (NYSE:PRGO) with a Buy and raises the price target from $17 to $19.
benzinga.com Perrigo To Sell Infant Formula Business To MeridianMade For Up To $175M; Co To Refocus On Consumer Self-Care Products Advances Streamline pillar of Perrigo's Three-S plan through portfolio simplificationFurthers Perrigo's evolution into a simpler, more focused consumer self-care companyExpected to enhance Perrigo's
benzinga.com Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields Analysts highlight high-yield healthcare stocks Perrigo (7.09%), Pfizer (5.65%) and CVS Health (2.82%), with updated ratings and news.